A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA)

By sjmartinez • February 15, 2023

Khanna D, Denton CP, Furst DE, Mayes MD, Matucci-Cerinic M, Smith V, de Vries D, Ford P, Bauer Y, Randall MJ, Ebrahimpoor M, Kupcsik L, Stiers PJ, Deberdt L, Prasad N, Lim S, Pujuguet P, Ahmed S. A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA). Arthritis Rheumatol. 2023 Feb 14. doi: 10.1002/art.42477. Epub ahead of print. PMID: 36787101.

Tags: Publications, Rheumatology

Coronary Artery Calcium for Risk Stratification of Heart Failure Mortality: The Coronary Artery Calcium Consortium

Mhaimeed O, Dardari ZA, Khorsandi M, Dzaye O, Sharma K, Nasir K, Berman DS, Budoff MJ, Shaw LJ, Rumberger JA, Miedema MD, Blaha MJ. Coronary[...]

The relation of heavy or prolonged bleeding during the menopause transition to risk of hysterectomy

Harlow SD, Hood MM, Mukwege A, Randolph JF Jr, Gold EB, Elliott MR, White AC, Greendale GA. The relation of heavy or prolonged bleeding during[...]

Oxygen dissociation curve inflection point during incremental exercise: a trigger for the Bohr effect

Burchert HH, Stringer WW, Dash RK. Oxygen dissociation curve inflection point during incremental exercise: a trigger for the Bohr effect. Pflugers Arch. 2025 Jul 10.[...]